Even though the expression of RPL15 and EEF1B2, hallmarks of the blue signature, were not significantly downregulated upon treatment with serum from pSS patients, IFNAR blockade significantly increased the expression of both genes. This evidence concerns the gene EEF1B2 and peeling skin syndrome.